her2dx assay and survival outcomes: an individual-patient level meta-analysis of 2,031 patients ...
Published 1 month ago • 21 plays • Length 3:32Download video MP4
Download video MP3
Similar videos
-
4:26
independent validation of the her2dx genomic test in her2-positive breast cancer
-
3:49
her2dx: a new diagnostic tool for early-stage her2 positive breast cancer
-
1:26
the association of the her2dx signatures with survival in tnbc
-
1:22
her2dx risk-score in early-stage her2-positive breast cancer
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
-
8:54
سؤال ع السريع: ما معنى her2 ايجابي وايه العمل لما يطلع 2 🙄🤔
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
8:25
new breast cancer drug delivers unprecedented levels of survival, stopping tumor growth
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
4:25
managing her2-positive breast cancer
-
1:01:35
her2 treatment
-
4:01
management of her2 positive metastatic breast cancer treatment algorithm
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
1:53:20
44- her2 positive disease
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
11:04
shorther trastuzumab treatment of her2 breast cancer: 9 weeks v 1 year
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score